Riekkinen M, Kejonen K, Jäkälä P, Soininen H, Riekkinen P
Department of Neuroscience, University Hospital and University of Kuopio, Finland.
Eur J Neurosci. 1998 Apr;10(4):1429-35. doi: 10.1046/j.1460-9568.1998.00145.x.
We investigated the role dopamine and noradrenaline in the modulation of attention in Parkinson's disease (PD) patients. We observed that PD patients with mild and moderate motor disability did not differ in their attentional accuracy in easy tests, but the severe PD group was slightly disrupted in a more arduous test of attention. Attentional accuracy was not affected by withdrawal of dopaminergic drugs in mild or severe PD patients. The movements of severe PD patients were slower, and withdrawal of dopaminergic drugs aggravated motor slowing more in severe PD patients. Clonidine (0.5 and 2 microg/kg) retarded accuracy of performance in the most difficult attention test in mild PD patients, but had no effect in the severe PD group. Clonidine had no effect on movement times. These data suggest that a defect in noradrenaline release may contribute to the impaired accuracy of attention in severe PD patients and that dopamine may be important for maintaining rapid motor responding.
我们研究了多巴胺和去甲肾上腺素在帕金森病(PD)患者注意力调节中的作用。我们观察到,轻度和中度运动功能障碍的PD患者在简单测试中的注意力准确性没有差异,但重度PD组在一项更艰巨的注意力测试中受到了轻微干扰。轻度或重度PD患者停用多巴胺能药物后,注意力准确性未受影响。重度PD患者的动作较慢,停用多巴胺能药物使重度PD患者的运动迟缓加重。可乐定(0.5和2微克/千克)在轻度PD患者最困难的注意力测试中降低了表现准确性,但在重度PD组中没有效果。可乐定对运动时间没有影响。这些数据表明,去甲肾上腺素释放缺陷可能导致重度PD患者注意力准确性受损,而多巴胺对于维持快速运动反应可能很重要。